Utility values for symptomatic non-severe hypoglycaemia elicited from persons with and without diabetes in Canada and the United Kingdom

Health and Quality of Life Outcomes

Volumn 6, Issue , 2008, Pages

  Levy, Adrian R ^a,b,c   Christensen, Torsten L U ^d   Johnson, Jeffrey A ^e  

^a ICON PLC   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ST PAUL S HOSPITAL   (Canada)

^d NOVO NORDISK A S   (Denmark)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; BODY WEIGHT; CANADA; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DRUG DOSE INCREASE; FEMALE; HEALTH STATUS; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; QUALITY OF LIFE; UNITED KINGDOM; ADOLESCENT; AGED; HYPOGLYCEMIC COMA; INSULIN DEPENDENT DIABETES MELLITUS; INTERVIEW; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; QUALITY ADJUSTED LIFE YEAR; SICKNESS IMPACT PROFILE; SOCIOECONOMICS; STATISTICS;

ADOLESCENT; ADULT; AGED; CANADA; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EPISODE OF CARE; FEMALE; GREAT BRITAIN; HEALTH STATUS; HUMANS; HYPOGLYCEMIA; INSULIN; INSULIN COMA; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SATISFACTION; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; SICKNESS IMPACT PROFILE; VALUE OF LIFE; YOUNG ADULT;

EID: 54149118010     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-6-73     Document Type: Article

References (30)

1. Davis RE Morrissey M Peters JR Wittrup-Jensen K Kennedy-Martin T Currie CJ Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes Curr Med Res Opin 2005, 21:1477-1483 10.1185/ 030079905X61929 16197667
2. Donnelly LA Morris AD Frier BM Ellis JD Donnan PT Durrant R Band MM Reekie G Leese GP Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: A population-based study Diabet Med 2005, 22:749-755 10.1111/j.1464-5491.2005.01501.x 15910627
3. Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia Diabetes Care 2005, 28:1245-1249 10.2337/diacare.28.5.1245 15855602
4. Lazaruk S Eye surgeon's widow awarded $6.4 million for his loss The Province. 10-5-2007. Vancouver
5. Nordfeldt S Jonsson D Short-term effects of severe hypoglycemia in children and adolescents with type 1 diabetes. A cost-of-illness study Acta Paediatr 2001, 90:137-142 10.1080/080352501300049244 11236041
6. Gonder-Frederick L Cox D Hypoglycemia Fear Survey - 1998 Version University of Virginia 1998
7. Sato E Ohsawa I Kataoka J Miwa M Tsukagoshi F Sato J Oshida Y Sato Y Socio-psychological problems of patients with late adolescent onset type 1 diabetes - analysis by qualitative research Nagoya J Med Sci 2003, 66:21-29 12848418
8. Gonder-Frederick L Cox D Kovatchev B Julian D Clarke W The psychosocial impact of severe hypoglycemic episodes on spouses of patients with IDDM Diabetes Care 1997, 20:1543-1546 10.2337/diacare.20.10.1543 9314632
9. Polonsky WH Davis CL Jacobson AM Anderson BJ Correlates of hypoglycemic fear in type I and type II diabetes mellitus Health Psychol 1992, 11:199-202 10.1037/0278-6133.11.3.199 1618174
10. Wild D von Maltzahn R Brohan E Christensen T Clauson P Gonder-Frederick L A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education Patient Educ Couns 2007, 68:10-15 10.1016/j.pec.2007.05.003 17582726
11. Costea M Ionescu-Tirgoviste C Cheta D Mincu I Fear of hypoglycemia in type 1 (insulin-dependent) diabetic patients Rom J Intern Med 1993, 31:291-295 8148782
12. Richmond J Effects of hypoglycemia: Patient's perceptions and experiences Brit J Nurs 1059, 5:1054-1996
13. Herbel G Boyle PJ Hypoglycemia. Pathophysiology and treatment Endocrinol Metab Clin North Am 2000, 29:725-743 10.1016/S0889-8529(05)70161-4 11149159
14. Currie CJ Morgan CL Poole CD Sharplin P Lammert M McEwan P Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes Curr Med Res Opin 2006, 22:1523-1534 10.1185/ 030079906X115757 16870077
15. Gold MR Siegel JE Russel LB Weinstein MC Cost-effectiveness in Health and Medicine New York, Oxford University Press 1996
16. Warren E Weatherley-Jones E Chilcott J Beverley C Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine Health Technol Assess 2004, 8:45 iii, 1 iii, 57
17. Bennet KJ Torrance GW Measuring health state preferences and utilities: rating scale, time trade-off and standard gamble techniques Quality of Life and Pharmacoeconomics in Clinical Trials Philadelphia, Lippincott-Raven Spilker B 2 1996:253-265
18. Torrance GW Utility approach to measuring health-related quality of life J Chronic Dis 1987, 40:593-603 10.1016/0021-9681(87)90019-1 3298297
19. De Wit GA Busschbach JJV De Charro FT Sensitivity and perspective in the valuation of health status: Whose values count? Health Economics 2000, 9:109-126 10.1002/ (SICI)1099-1050(200003)9:2<109::AID-HEC503>3.0.CO;2-L 10721013
20. Guide to the Methods of Technology Appraisal. N0515 London, National Institute for Clinical Excellence 2004
21. Cox DJ Irvine A Gonder-Frederick L Nowacek G Butterfield J Fear of hypoglycemia: Quantification, validation, and utilization Diabetes Care 1987, 10:617-621 10.2337/diacare.10.5.617 3677982
22. Torrance GW Measurement of health state utilities for economic appraisal J Health Econ 1986, 5:1-30 10.1016/0167-6296(86)90020-2 10311607
23. Hoffmann JP Generalized linear models: An applied approach Boston, Pearson Education Inc 2004
24. Papke LE Wooldridge JM Econometric methods for fractional response variables with an application to 401(k) plan participation rates Journal of Applied Econometrics 1996, 11:619-632 10.1002/ (SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1
25. Maddigan SL Feeny DH Johnson JA Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey Qual Life Res 2005, 14:1311-1320 10.1007/ s11136-004-6640-4 16047506
26. Maddigan SL Feeny DH Majumdar SR Farris KB Johnson JA Health Utilities Index mark 3 demonstrated construct validity in a population-based sample with type 2 diabetes J Clin Epidemiol 2006, 59:472-477 10.1016/ j.jclinepi.2005.09.010 16632135
27. Lundkvist J Berne C Bolinder B Jonsson L The economic and quality of life impact of hypoglycemia Eur J Health Econ 2005, 6:197-202 10.1007/ s10198-005-0276-3 15761775
28. Nordfeldt S Ludvigsson J Fear and other diturbances of severe hypoglycemia in children and adolescents with type 1diabetes mellitus J Pediatr Endocrinol Metab 2005, 18:83-91 15679073
29. Matza LS Boye KS Yurgin N Brewster-Jordan J Mannix S Shorr JM Barber BL Utilities and disutilities for type 2 diabetes treatment-related attributes Qual Life Res 2007, 16:1251-1265 10.1007/s11136-007-9226-0 17638121
30. Lipscombe LL Hux JE Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: A population-based study Lancet 2007, 369:750-756 10.1016/S0140-6736(07)60361-4 17336651